Senseonics (NYSE:SENS) announced preliminary financial results for 2024 as it considers a reverse stock split.

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it signed a multi-year R&D collaboration agreement with the ...

CeQur announced today that it closed a $120 million financing round to support its wearable insulin delivery technology.

Phillips Medisize parent company Molex has completed its acquisition of Vectura from a subsidiary of cigarette maker Philip ...

Glooko and Hedia announced today that launched their interoperable solution for advanced bolus insulin dosing support.

PreEvnt recently announced plans to introduce Isaac, its non-invasive alert device for monitoring blood glucose levels.

Beta Bionics announced today that it filed a registration statement with the SEC relating to a proposed initial public ...

Left, the Dexcom G7 CGM. Right, the Abbott FreeStyle Libre 2. [Images from Dexcom and Abbott] The Unified Patent Court in Paris sided with Abbott (NYSE:ABT) following a CGM patent infringement claim ...

Qnovia’s nicotine replacement therapy device. [Image courtesy of Qnovia] Qnovia announced that it raised $16 million in Series B funding to support its inhaled smoking cessation therapy platform. Blue ...

Left, the Dexcom G7 CGM. Right, the Abbott FreeStyle Libre 2. [Images from Dexcom and Abbott] Abbott (NYSE:ABT) announced today that it reached an agreement with Dexcom (Nasdaq:DXCM) to settle all ...

The Vivani NanoPortal technology. [Image courtesy of Vivani] Vivani Medical (Nasdaq:VANI) announced today that it initiated screening and enrollment for a first-in-human trial of its GLP-1 implant.